Inhibition of Cell Proliferation and Metastasis by Scutellarein Regulating PI3K/Akt/NF-κB Signaling through PTEN Activation in Hepatocellular Carcinoma
Scutellarein (SCU) is a well-known flavone with a broad range of biological activities against several cancers. Human hepatocellular carcinoma (HCC) is major cancer type due to its poor prognosis even after treatment with chemotherapeutic drugs, which causes a variety of side effects in patients. Th...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396260/ https://www.ncbi.nlm.nih.gov/pubmed/34445559 http://dx.doi.org/10.3390/ijms22168841 |
_version_ | 1783744331939577856 |
---|---|
author | Ha, Sang Eun Kim, Seong Min Vetrivel, Preethi Kim, Hun Hwan Bhosale, Pritam Bhagwan Heo, Jeong Doo Lee, Ho Jeong Kim, Gon Sup |
author_facet | Ha, Sang Eun Kim, Seong Min Vetrivel, Preethi Kim, Hun Hwan Bhosale, Pritam Bhagwan Heo, Jeong Doo Lee, Ho Jeong Kim, Gon Sup |
author_sort | Ha, Sang Eun |
collection | PubMed |
description | Scutellarein (SCU) is a well-known flavone with a broad range of biological activities against several cancers. Human hepatocellular carcinoma (HCC) is major cancer type due to its poor prognosis even after treatment with chemotherapeutic drugs, which causes a variety of side effects in patients. Therefore, efforts have been made to develop effective biomarkers in the treatment of HCC in order to improve therapeutic outcomes using natural based agents. The current study used SCU as a treatment approach against HCC using the HepG2 cell line. Based on the cell viability assessment up to a 200 μM concentration of SCU, three low-toxic concentrations of (25, 50, and 100) μM were adopted for further investigation. SCU induced cell cycle arrest at the G2/M phase and inhibited cell migration and proliferation in HepG2 cells in a dose-dependent manner. Furthermore, increased PTEN expression by SCU led to the subsequent downregulation of PI3K/Akt/NF-κB signaling pathway related proteins. In addition, SCU regulated the metastasis with EMT and migration-related proteins in HepG2 cells. In summary, SCU inhibits cell proliferation and metastasis in HepG2 cells through PI3K/Akt/NF-κB signaling by upregulation of PTEN, suggesting that SCU might be used as a potential agent for HCC therapy. |
format | Online Article Text |
id | pubmed-8396260 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83962602021-08-28 Inhibition of Cell Proliferation and Metastasis by Scutellarein Regulating PI3K/Akt/NF-κB Signaling through PTEN Activation in Hepatocellular Carcinoma Ha, Sang Eun Kim, Seong Min Vetrivel, Preethi Kim, Hun Hwan Bhosale, Pritam Bhagwan Heo, Jeong Doo Lee, Ho Jeong Kim, Gon Sup Int J Mol Sci Article Scutellarein (SCU) is a well-known flavone with a broad range of biological activities against several cancers. Human hepatocellular carcinoma (HCC) is major cancer type due to its poor prognosis even after treatment with chemotherapeutic drugs, which causes a variety of side effects in patients. Therefore, efforts have been made to develop effective biomarkers in the treatment of HCC in order to improve therapeutic outcomes using natural based agents. The current study used SCU as a treatment approach against HCC using the HepG2 cell line. Based on the cell viability assessment up to a 200 μM concentration of SCU, three low-toxic concentrations of (25, 50, and 100) μM were adopted for further investigation. SCU induced cell cycle arrest at the G2/M phase and inhibited cell migration and proliferation in HepG2 cells in a dose-dependent manner. Furthermore, increased PTEN expression by SCU led to the subsequent downregulation of PI3K/Akt/NF-κB signaling pathway related proteins. In addition, SCU regulated the metastasis with EMT and migration-related proteins in HepG2 cells. In summary, SCU inhibits cell proliferation and metastasis in HepG2 cells through PI3K/Akt/NF-κB signaling by upregulation of PTEN, suggesting that SCU might be used as a potential agent for HCC therapy. MDPI 2021-08-17 /pmc/articles/PMC8396260/ /pubmed/34445559 http://dx.doi.org/10.3390/ijms22168841 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ha, Sang Eun Kim, Seong Min Vetrivel, Preethi Kim, Hun Hwan Bhosale, Pritam Bhagwan Heo, Jeong Doo Lee, Ho Jeong Kim, Gon Sup Inhibition of Cell Proliferation and Metastasis by Scutellarein Regulating PI3K/Akt/NF-κB Signaling through PTEN Activation in Hepatocellular Carcinoma |
title | Inhibition of Cell Proliferation and Metastasis by Scutellarein Regulating PI3K/Akt/NF-κB Signaling through PTEN Activation in Hepatocellular Carcinoma |
title_full | Inhibition of Cell Proliferation and Metastasis by Scutellarein Regulating PI3K/Akt/NF-κB Signaling through PTEN Activation in Hepatocellular Carcinoma |
title_fullStr | Inhibition of Cell Proliferation and Metastasis by Scutellarein Regulating PI3K/Akt/NF-κB Signaling through PTEN Activation in Hepatocellular Carcinoma |
title_full_unstemmed | Inhibition of Cell Proliferation and Metastasis by Scutellarein Regulating PI3K/Akt/NF-κB Signaling through PTEN Activation in Hepatocellular Carcinoma |
title_short | Inhibition of Cell Proliferation and Metastasis by Scutellarein Regulating PI3K/Akt/NF-κB Signaling through PTEN Activation in Hepatocellular Carcinoma |
title_sort | inhibition of cell proliferation and metastasis by scutellarein regulating pi3k/akt/nf-κb signaling through pten activation in hepatocellular carcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396260/ https://www.ncbi.nlm.nih.gov/pubmed/34445559 http://dx.doi.org/10.3390/ijms22168841 |
work_keys_str_mv | AT hasangeun inhibitionofcellproliferationandmetastasisbyscutellareinregulatingpi3kaktnfkbsignalingthroughptenactivationinhepatocellularcarcinoma AT kimseongmin inhibitionofcellproliferationandmetastasisbyscutellareinregulatingpi3kaktnfkbsignalingthroughptenactivationinhepatocellularcarcinoma AT vetrivelpreethi inhibitionofcellproliferationandmetastasisbyscutellareinregulatingpi3kaktnfkbsignalingthroughptenactivationinhepatocellularcarcinoma AT kimhunhwan inhibitionofcellproliferationandmetastasisbyscutellareinregulatingpi3kaktnfkbsignalingthroughptenactivationinhepatocellularcarcinoma AT bhosalepritambhagwan inhibitionofcellproliferationandmetastasisbyscutellareinregulatingpi3kaktnfkbsignalingthroughptenactivationinhepatocellularcarcinoma AT heojeongdoo inhibitionofcellproliferationandmetastasisbyscutellareinregulatingpi3kaktnfkbsignalingthroughptenactivationinhepatocellularcarcinoma AT leehojeong inhibitionofcellproliferationandmetastasisbyscutellareinregulatingpi3kaktnfkbsignalingthroughptenactivationinhepatocellularcarcinoma AT kimgonsup inhibitionofcellproliferationandmetastasisbyscutellareinregulatingpi3kaktnfkbsignalingthroughptenactivationinhepatocellularcarcinoma |